Nantahala Capital Management’s DarioHealth DRIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.03M Buy
610,691
+1
+0% +$7 0.13% 114
2026
Q1
$4.9M Buy
610,690
+47,458
+8% +$495K 0.18% 100
2025
Q4
$6.41M Sell
563,232
-1
-0% -$13 0.21% 93
2025
Q3
$9.77M Buy
563,233
+478,618
+566% +$5.27M 0.34% 69
2025
Q2
$1.13M Hold
84,615
0.04% 135
2025
Q1
$1.04M Sell
84,615
-37,619
-31% -$531K 0.04% 123
2024
Q4
$1.92M Sell
122,234
-2,932
-2% -$50.7K 0.08% 109
2024
Q3
$2.8M Buy
125,166
+5,600
+5% +$114K 0.14% 91
2024
Q2
$2.85M Sell
119,566
-12,062
-9% -$342K 0.17% 82
2024
Q1
$4.03M Buy
131,628
+14,790
+13% +$561K 0.23% 73
2023
Q4
$4.02M Sell
116,838
-3,872
-3% -$138K 0.24% 70
2023
Q3
$7.92M Sell
120,710
-215
-0.2% -$14.5K 0.68% 37
2023
Q2
$9.7M Hold
120,925
0.94% 27
2023
Q1
$9.96M Sell
120,925
-2,413
-2% -$237K 0.76% 28
2022
Q4
$10.6M Buy
123,338
+13,569
+12% +$1.22M 0.68% 34
2022
Q3
$10.2M Buy
109,769
+23,228
+27% +$2.49M 0.66% 40
2022
Q2
$10.6M Buy
86,541
+741
+0.9% +$86.9K 0.53% 41
2022
Q1
$10M Buy
85,800
+15,216
+22% +$2.52M 0.44% 41
2021
Q4
$18.3M Buy
70,584
+17,408
+33% +$5.29M 0.64% 37
2021
Q3
$14.5M Hold
53,176
0.46% 52
2021
Q2
$22.7M Buy
53,176
+15,666
+42% +$5.96M 0.65% 39
2021
Q1
$14.4M Buy
37,510
+7,799
+26% +$3.51M 0.42% 51
2020
Q4
$8.49M Hold
29,711
0.26% 75
2020
Q3
$9.97M Buy
29,711
+19,006
+178% +$5.14M 0.31% 68
2020
Q2
$1.36M Hold
10,705
0.04% 104
2020
Q1
$1.45M Hold
10,705
0.05% 98
2019
Q4
$1.4M Buy
10,705
+1
+0% +$110 0.04% 82
2019
Q3
$1.3M Hold
10,704
0.05% 86
2019
Q2
$2.27M Buy
10,704
+2,327
+28% +$604K 0.07% 87
2019
Q1
$2.47M Hold
8,377
0.08% 80
2018
Q4
$2.7M Buy
+8,377
New +$3.01M 0.08% 88

Other funds holding DRIO

Nantahala Capital Management's DRIO Position: Q2 2026 in Review

Nantahala Capital Management increased its DarioHealth (DRIO) stake by 0% in Q2 2026, buying an estimated $7 and bringing the position to 610,691 shares worth $4.03M. The position accounts for 0.13% of the portfolio, ranked #114.

Nantahala Capital Management first reported a position in DRIO in Q4 2018 and has held it in 31 quarters since. The position peaked at $22.7M in Q2 2021. 21 funds tracked by Wall St. Rank hold DRIO as of Q2 2026.

  • Nantahala Capital Management held 610,691 shares of DarioHealth worth $4.03M as of Q2 2026.
  • Nantahala Capital Management bought 1 DarioHealth share in Q2 2026, an estimated $7.
  • DarioHealth made up 0.13% of Nantahala Capital Management's portfolio in Q2 2026, its #114 holding.
  • Nantahala Capital Management first reported a position in DarioHealth in Q4 2018 and has held it in 31 quarters since.
  • Nantahala Capital Management's DarioHealth position peaked at $22.7M in Q2 2021.
  • 21 funds tracked by Wall St. Rank held DarioHealth as of Q2 2026.

Based on Nantahala Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.